HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 11-MAR-10 3M4H
TITLE HUMAN ALDOSE REDUCTASE MUTANT T113V COMPLEXED WITH IDD388
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: ALDOSE REDUCTASE;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: AR, ALDEHYDE REDUCTASE, ALDO-KETO REDUCTASE FAMILY 1 MEMBER
COMPND 5 B1;
COMPND 6 EC: 1.1.1.21;
COMPND 7 ENGINEERED: YES;
COMPND 8 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: ALR2;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 GOLD;
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B
KEYWDS T113V MUTANT, OXIDOREDUCTASE, NADP, PHOSPHOPROTEIN, OXIDOREDUCTASE-
KEYWDS 2 OXIDOREDUCTASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR C.KOCH,A.HEINE,G.KLEBE
REVDAT 3 20-MAR-24 3M4H 1 REMARK SEQADV
REVDAT 2 24-AUG-11 3M4H 1 JRNL VERSN
REVDAT 1 15-DEC-10 3M4H 0
JRNL AUTH C.KOCH,A.HEINE,G.KLEBE
JRNL TITL TRACING THE DETAIL: HOW MUTATIONS AFFECT BINDING MODES AND
JRNL TITL 2 THERMODYNAMIC SIGNATURES OF CLOSELY RELATED ALDOSE REDUCTASE
JRNL TITL 3 INHIBITORS
JRNL REF J.MOL.BIOL. V. 406 700 2011
JRNL REFN ISSN 0022-2836
JRNL PMID 21185307
JRNL DOI 10.1016/J.JMB.2010.11.058
REMARK 2
REMARK 2 RESOLUTION. 0.94 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNS
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 0.94
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 98.5
REMARK 3 CROSS-VALIDATION METHOD : FREE R
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF).
REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.103
REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.103
REMARK 3 FREE R VALUE (NO CUTOFF) : 0.122
REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 9821
REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 196117
REMARK 3
REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F).
REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.097
REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.096
REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.115
REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 8855
REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 175991
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2490
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 86
REMARK 3 SOLVENT ATOMS : 412
REMARK 3
REMARK 3 MODEL REFINEMENT.
REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2969.5
REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 2487.0
REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 50
REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 29528
REMARK 3 NUMBER OF RESTRAINTS : 40327
REMARK 3
REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES.
REMARK 3 BOND LENGTHS (A) : 0.009
REMARK 3 ANGLE DISTANCES (A) : 0.025
REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000
REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.031
REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.114
REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.107
REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.037
REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.004
REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.046
REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.090
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED: NULL
REMARK 3
REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER
REMARK 3 SPECIAL CASE: NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: ANISOTROPIC SCALING APPLIED BY THE
REMARK 3 METHOD OF PARKIN, MOEZZI & HOPE, J.APPL.CRYST.28(1995)53-56
REMARK 3 ANISOTROPIC REFINEMENT REDUCED FREE R (NO CUTOFF) BY ?
REMARK 4
REMARK 4 3M4H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 30-MAR-10.
REMARK 100 THE DEPOSITION ID IS D_1000058096.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 07-NOV-08
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 5.0
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : BESSY
REMARK 200 BEAMLINE : 14.2
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841
REMARK 200 MONOCHROMATOR : SI-111 CRYSTAL
REMARK 200 OPTICS : SILICON, RH-COATED
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 206641
REMARK 200 RESOLUTION RANGE HIGH (A) : 0.920
REMARK 200 RESOLUTION RANGE LOW (A) : 20.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 97.3
REMARK 200 DATA REDUNDANCY : 3.000
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : 0.04200
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 23.9000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.92
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 0.94
REMARK 200 COMPLETENESS FOR SHELL (%) : 77.8
REMARK 200 DATA REDUNDANCY IN SHELL : 2.00
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : 0.30900
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.600
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS
REMARK 200 SOFTWARE USED: CNS
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 43.53
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.04
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 6000, 120MM AMMONIUM CITRATE,
REMARK 280 PH 5.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.44000
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 GLU A 126 CG CD OE1 OE2
REMARK 470 LYS A 194 CG CD CE NZ
REMARK 470 LYS A 221 CG CD CE NZ
REMARK 470 GLU A 223 CG CD OE1 OE2
REMARK 470 HIS A 312 CG ND1 CD2 CE1 NE2
REMARK 470 GLU A 313 CG CD OE1 OE2
REMARK 470 GLU A 314 CG CD OE1 OE2
REMARK 470 PHE A 315 CG CD1 CD2 CE1 CE2 CZ
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 MET A 0 CG - SD - CE ANGL. DEV. = 10.3 DEGREES
REMARK 500 THR A 135 N - CA - CB ANGL. DEV. = 11.4 DEGREES
REMARK 500 TYR A 209 CA - CB - CG ANGL. DEV. = 14.8 DEGREES
REMARK 500 ARG A 293 CD - NE - CZ ANGL. DEV. = 10.2 DEGREES
REMARK 500 ARG A 293 NE - CZ - NH2 ANGL. DEV. = 3.6 DEGREES
REMARK 500 TRP A 295 O - C - N ANGL. DEV. = 10.8 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 LYS A 21 -1.80 80.65
REMARK 500 PRO A 112 36.04 -76.15
REMARK 500 ARG A 293 26.18 -142.55
REMARK 500
REMARK 500 REMARK: NULL
REMARK 600
REMARK 600 HETEROGEN
REMARK 600
REMARK 600 BR A 800 IS A CLEAVAGE PRODUCT OF INHIBITOR 388 A 600
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A 500
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 388 A 600
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CIT A 700
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BR A 800
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 3LZ5 RELATED DB: PDB
REMARK 900 HUMAN ALDOSE REDUCTASE MUTANT T113V COMPLEXED WITH IDD594
REMARK 900 RELATED ID: 3M0I RELATED DB: PDB
REMARK 900 HUMAN ALDOSE REDUCTASE MUTANT T113V COMPLEXED WITH ZOPOLRESTAT
REMARK 900 RELATED ID: 3LQG RELATED DB: PDB
REMARK 900 HUMAN ALDOSE REDUCTASE MUTANT T113A COMPLEXED WITH IDD388
REMARK 900 RELATED ID: 3LEP RELATED DB: PDB
REMARK 900 HUMAN ALDOSE REDUCTASE MUTANT T113C COMPLEXED WITH IDD388
REMARK 900 RELATED ID: 3LZ3 RELATED DB: PDB
REMARK 900 HUMAN ALDOSE REDUCTASE MUTANT T113S COMPLEXED WITH IDD388
REMARK 900 RELATED ID: 2IKI RELATED DB: PDB
REMARK 900 HUMAN ALDOSE REDUCTASE COMPLEXED WITH IDD388
REMARK 900 RELATED ID: 3LQL RELATED DB: PDB
REMARK 900 RELATED ID: 3LBO RELATED DB: PDB
REMARK 900 RELATED ID: 3LD5 RELATED DB: PDB
REMARK 999
REMARK 999 SEQUENCE
REMARK 999 THIS SEQUENCE CONFLICT HAS BEEN DESCRIBED IN
REMARK 999 J BIOL CHEM 1989 SEP 5; 264(25): 14775-7 BY CHUNG S, ET AL.,
REMARK 999 PUBMED ID 2504709
DBREF 3M4H A 0 315 UNP P15121 ALDR_HUMAN 1 316
SEQADV 3M4H ILE A 4 UNP P15121 LEU 5 SEE REMARK 999
SEQADV 3M4H VAL A 113 UNP P15121 THR 114 ENGINEERED MUTATION
SEQRES 1 A 316 MET ALA SER ARG ILE LEU LEU ASN ASN GLY ALA LYS MET
SEQRES 2 A 316 PRO ILE LEU GLY LEU GLY THR TRP LYS SER PRO PRO GLY
SEQRES 3 A 316 GLN VAL THR GLU ALA VAL LYS VAL ALA ILE ASP VAL GLY
SEQRES 4 A 316 TYR ARG HIS ILE ASP CYS ALA HIS VAL TYR GLN ASN GLU
SEQRES 5 A 316 ASN GLU VAL GLY VAL ALA ILE GLN GLU LYS LEU ARG GLU
SEQRES 6 A 316 GLN VAL VAL LYS ARG GLU GLU LEU PHE ILE VAL SER LYS
SEQRES 7 A 316 LEU TRP CYS THR TYR HIS GLU LYS GLY LEU VAL LYS GLY
SEQRES 8 A 316 ALA CYS GLN LYS THR LEU SER ASP LEU LYS LEU ASP TYR
SEQRES 9 A 316 LEU ASP LEU TYR LEU ILE HIS TRP PRO VAL GLY PHE LYS
SEQRES 10 A 316 PRO GLY LYS GLU PHE PHE PRO LEU ASP GLU SER GLY ASN
SEQRES 11 A 316 VAL VAL PRO SER ASP THR ASN ILE LEU ASP THR TRP ALA
SEQRES 12 A 316 ALA MET GLU GLU LEU VAL ASP GLU GLY LEU VAL LYS ALA
SEQRES 13 A 316 ILE GLY ILE SER ASN PHE ASN HIS LEU GLN VAL GLU MET
SEQRES 14 A 316 ILE LEU ASN LYS PRO GLY LEU LYS TYR LYS PRO ALA VAL
SEQRES 15 A 316 ASN GLN ILE GLU CYS HIS PRO TYR LEU THR GLN GLU LYS
SEQRES 16 A 316 LEU ILE GLN TYR CYS GLN SER LYS GLY ILE VAL VAL THR
SEQRES 17 A 316 ALA TYR SER PRO LEU GLY SER PRO ASP ARG PRO TRP ALA
SEQRES 18 A 316 LYS PRO GLU ASP PRO SER LEU LEU GLU ASP PRO ARG ILE
SEQRES 19 A 316 LYS ALA ILE ALA ALA LYS HIS ASN LYS THR THR ALA GLN
SEQRES 20 A 316 VAL LEU ILE ARG PHE PRO MET GLN ARG ASN LEU VAL VAL
SEQRES 21 A 316 ILE PRO LYS SER VAL THR PRO GLU ARG ILE ALA GLU ASN
SEQRES 22 A 316 PHE LYS VAL PHE ASP PHE GLU LEU SER SER GLN ASP MET
SEQRES 23 A 316 THR THR LEU LEU SER TYR ASN ARG ASN TRP ARG VAL CYS
SEQRES 24 A 316 ALA LEU LEU SER CYS THR SER HIS LYS ASP TYR PRO PHE
SEQRES 25 A 316 HIS GLU GLU PHE
HET NAP A 500 48
HET 388 A 600 24
HET CIT A 700 13
HET BR A 800 1
HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE
HETNAM 388 (2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-
HETNAM 2 388 CHLOROPHENOXY)ACETIC ACID
HETNAM CIT CITRIC ACID
HETNAM BR BROMIDE ION
HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE
HETSYN 388 IDD388
FORMUL 2 NAP C21 H28 N7 O17 P3
FORMUL 3 388 C16 H12 BR CL F N O4
FORMUL 4 CIT C6 H8 O7
FORMUL 5 BR BR 1-
FORMUL 6 HOH *412(H2 O)
HELIX 1 1 PRO A 23 GLY A 38 1 16
HELIX 2 2 ALA A 45 GLN A 49 5 5
HELIX 3 3 ASN A 50 GLU A 64 1 15
HELIX 4 4 LYS A 68 LEU A 72 5 5
HELIX 5 5 TRP A 79 HIS A 83 5 5
HELIX 6 6 LEU A 87 LYS A 100 1 14
HELIX 7 7 ASN A 136 GLU A 150 1 15
HELIX 8 8 ASN A 162 ASN A 171 1 10
HELIX 9 9 GLN A 192 LYS A 202 1 11
HELIX 10 10 SER A 226 GLU A 229 5 4
HELIX 11 11 ASP A 230 ASN A 241 1 12
HELIX 12 12 THR A 243 GLN A 254 1 12
HELIX 13 13 THR A 265 LYS A 274 1 10
HELIX 14 14 SER A 281 SER A 290 1 10
HELIX 15 15 LEU A 300 THR A 304 5 5
SHEET 1 A 2 ARG A 3 LEU A 5 0
SHEET 2 A 2 LYS A 11 PRO A 13 -1 O MET A 12 N ILE A 4
SHEET 1 B 8 LEU A 17 GLY A 18 0
SHEET 2 B 8 HIS A 41 ASP A 43 1 O ASP A 43 N LEU A 17
SHEET 3 B 8 PHE A 73 LEU A 78 1 O VAL A 75 N ILE A 42
SHEET 4 B 8 LEU A 106 ILE A 109 1 O LEU A 108 N LEU A 78
SHEET 5 B 8 ILE A 156 SER A 159 1 O GLY A 157 N ILE A 109
SHEET 6 B 8 VAL A 181 GLU A 185 1 O VAL A 181 N ILE A 158
SHEET 7 B 8 VAL A 205 TYR A 209 1 O THR A 207 N ILE A 184
SHEET 8 B 8 VAL A 258 VAL A 259 1 O VAL A 258 N ALA A 208
SITE 1 AC1 34 GLY A 18 THR A 19 TRP A 20 LYS A 21
SITE 2 AC1 34 ASP A 43 TYR A 48 LYS A 77 HIS A 110
SITE 3 AC1 34 SER A 159 ASN A 160 GLN A 183 TYR A 209
SITE 4 AC1 34 SER A 210 PRO A 211 LEU A 212 GLY A 213
SITE 5 AC1 34 SER A 214 PRO A 215 ASP A 216 ALA A 245
SITE 6 AC1 34 ILE A 260 PRO A 261 LYS A 262 SER A 263
SITE 7 AC1 34 VAL A 264 THR A 265 ARG A 268 GLU A 271
SITE 8 AC1 34 ASN A 272 388 A 600 HOH A1097 HOH A1113
SITE 9 AC1 34 HOH A1149 HOH A1391
SITE 1 AC2 12 TRP A 20 VAL A 47 TYR A 48 HIS A 110
SITE 2 AC2 12 TRP A 111 VAL A 113 CYS A 298 ALA A 299
SITE 3 AC2 12 LEU A 300 NAP A 500 BR A 800 HOH A1059
SITE 1 AC3 16 GLN A 49 ASN A 50 GLU A 51 ASN A 52
SITE 2 AC3 16 GLU A 53 LYS A 94 ASP A 98 HOH A1019
SITE 3 AC3 16 HOH A1049 HOH A1085 HOH A1131 HOH A1153
SITE 4 AC3 16 HOH A1199 HOH A1210 HOH A1242 HOH A1307
SITE 1 AC4 4 TRP A 111 VAL A 113 LEU A 300 388 A 600
CRYST1 49.390 66.880 47.370 90.00 92.11 90.00 P 1 21 1 2
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.020249 0.000000 0.000746 0.00000
SCALE2 0.000000 0.014951 0.000000 0.00000
SCALE3 0.000000 0.000000 0.021125 0.00000